Clinical Outcomes and Safety: A Registry Study of Ilaris (Canakinumab) Patients

Ilaris (Canakinumab) in the Schnitzler Syndrome

NCT01245127 ·Status: COMPLETED ·Phase: PHASE2

Rilonacept for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)

NCT00288704 ·Status: COMPLETED ·Phase: PHASE3

An Efficacy and Safety Study of GNR-086 (Canakinumab Biosimilar) and Ilaris® in Patients With Adult-onset Still's Disease

NCT06497491 ·Status: COMPLETED ·Phase: PHASE3

Study of the ITK Inhibitor Soquelitinib to Reduce Lymphoproliferation and Improve Cytopenias in Autoimmune Lymphoproliferative Syndrome (ALPS)-FAS Patients

NCT06730126 ·Status: RECRUITING ·Phase: PHASE2

Inhibition of Anaphylaxis by Ibrutinib

NCT03149315 ·Status: COMPLETED ·Phase: PHASE2

Efficacy of Rituximab For the Treatment of Calcineurin Inhibitors Dependent Nephrotic Syndrome During Childhood

NCT01268033 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Ilaris (Canakinumab) in Patient With Periodic Fever, Aphthous Stomatitis, Pharyngitis and Cervical Adenitis (PFAPA)

NCT02775994 ·Status: UNKNOWN ·Phase: PHASE1

A Safety, Pharmacokinetics and Pharmacodynamics Study of GNR-086 and Ilaris® in Healthy Volunteers

NCT06481189 ·Status: COMPLETED ·Phase: PHASE1

A Single Dose Study To Test Two Pediatric Forms Of Ritlecitinib Compared With Adult Ritlecitinib In Healthy Adults

NCT05040295 ·Status: COMPLETED ·Phase: PHASE1

Lanadelumab in FXII-associated Cold Autoinflammatory Syndrome (FACAS)

NCT04278885 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN

NCT06994845 ·Status: RECRUITING ·Phase: PHASE3

Phase 2 Study of AKCEA-ANGPTL3-LRx (ISIS 703802) in Participants With Familial Chylomicronemia Syndrome (FCS)

NCT03360747 ·Status: COMPLETED ·Phase: PHASE2

Leniolisib for Immune Dysregulation in PIDs

NCT06549114 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Evaluate the Safety and Efficacy of Canakinumab in Pediatric Patients With Colchicine Intolerant or Colchicine Resistant Familial Mediterranean Fever (FMF)

NCT01148797 ·Status: COMPLETED ·Phase: PHASE2

Study to Investigate Safety, Efficacy of an Anti-IFNγ mAb in Children With Primary Haemophagocytic Lymphohistiocytosis

NCT01818492 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Ipilimumab 12-month Intensive Pharmacovigilance Protocol

NCT02050594 ·Status: COMPLETED

Anifrolumab for Hidradenitis Suppurativa

NCT06374212 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Study to Evaluate the Safety and Tolerability of Two Doses of Rilonacept in Pediatric Subjects With Active Systemic Juvenile Idiopathic Arthritis (SJIA)

NCT01803321 ·Status: COMPLETED ·Phase: PHASE1

Phase III Study Assessing the Efficacy and Safety of Pegcetacoplan in Patients With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis

NCT05067127 ·Status: COMPLETED ·Phase: PHASE3

Evaluate Safety and Pharmacokinetics of INF904 in Subjects With Moderate to Severe Chronic Spontaneous Urticaria or Hidradenitis Suppurativa

NCT06555328 ·Status: TERMINATED ·Phase: PHASE2

A Study of ELAPRASE in Treatment-naïve Participants With Hunter Syndrome (Mucopolysaccharidosis [MPS] II)

NCT05494593 ·Status: WITHDRAWN ·Phase: PHASE4

Ibrutinib in Combination With Corticosteroids vs Placebo in Combination With Corticosteroids in Participants With New Onset Chronic Graft Versus Host Disease (cGVHD)

NCT02959944 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Efalizumab in the Treatment of Moderate-Severe Hydradenitis Suppurativa

NCT00134134 ·Status: COMPLETED ·Phase: PHASE1

Healthy-donor Microbiome MTP-101-C in Steroid Relapse/Refractory Immune-related Cutaneous Adverse Events (irCAEs) and Immune-mediated Colitis (IMC)

NCT06499896 ·Status: RECRUITING ·Phase: PHASE2

Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Chronic Graft Versus Host Disease

NCT02195869 ·Status: COMPLETED ·Phase: PHASE1/PHASE2